Trial Profile
POL 7080 administered as single ascending doses in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Murepavadin (Primary)
- Indications Pseudomonal infections
- Focus Adverse reactions; Pharmacokinetics
- 02 Jun 2011 New trial record
- 10 May 2011 Results presented at the 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy.